Back to results
US 2008/0188658 A1Published application
Novel synthesis of gatifloxacin
AssigneeTeva Pharmaceuticals USA, Inc.
InventorsValerie Niddam-Hildesheim, Ben-Zion Dolitzky, Gideon Pilarski, Greta Sterimbaum
Life of this patent
Estimating the term…
Abstract
Provided is a method for making (±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolenecarboxylic acid, commonly known as gatifloxacin, in high purity, in a suspension in a dipolar aprotic solvent.
Claims21
A process for making gatifloxacin comprising the steps of:
- (a) heating a reaction mixture comprising 2-methylpiperazine and 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid in a dipolar aprotic solvent to a reaction temperature between about 40° C. and about 70° C. in a atmosphere of inert gas for a period of time sufficient to obtain gatifloxacin,
- (b) maintaining the reaction mixture at a holding temperature of about 40° C. or less to precipitate the gatifloxacin from the reaction mixture, and
- (c) isolating the precipitated gatifloxacin from the reaction mixture,
- wherein the reaction mixture is maintained in step (b) for a holding time sufficiently long so that there is no further increase in percent precipitate for a period of about one-half hour.
1 more element
In a process for making gatifloxacin, the steps of:
- (a) heating a reaction mixture comprising a suspension of 2-methylpiperazine and 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid in a dipolar aprotic solvent to a reaction temperature between about 50° C. and about 60° C. in a atmosphere of nitrogen or argon for a period of time sufficient to obtain gatifloxacin, and
- (b) maintaining the reaction mixture at a holding temperature of about 40° C. or less to precipitate the gatifloxacin from the reaction mixture, and
- wherein the dipolar aprotic solvent is selected from the group consisting of N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, and N-methylpyrolidone, and mixtures thereof, and
- the reaction mixture is maintained in step (b) for a holding time sufficiently long so that there is no further increase in percent precipitate for a period of about one-half hour.
1 more element
In a method of making gatifloxacin having about 0.07 area-% or less desmethyl gatifloxacin and about 0.06 area-% or less 2′-methyl gatifloxacin, the steps of:
- (a) heating a reaction mixture comprising 2-methylpiperazine and 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid in a dipolar aprotic solvent to a reaction temperature between about 53° C. and about 57° C. in a atmosphere of nitrogen or argon for a period of time sufficient to obtain gatifloxacin, and
- (b) maintaining the reaction mixture at a holding temperature of about 25° C. or less for a holding time of about 12 to about 24 hours to precipitate the gatifloxacin from the reaction mixture,
- (c) isolating the precipitated gatifloxacin from the reaction mixture,
- (d) slurrying the isolated gatiflaoxacin with water or a mixture of water and acetonitrile at a temperature of about 20° C. to about 30° C. for a slurry time, and
- (e) isolating gatifloxacin having about 0.07 area-% or less desmethyl gatifloxacin and about 0.06 area-% or less 2′-methyl gatifloxacin from the slurry,
- wherein the dipolar aprotic solvent is selected from the group consisting of N,N-dimethylformamide, N,N-dimethylacetamide, dimethylsulfoxide, and N-methylpyrolidone, and mixtures thereof.
3 more elements
Dependencies are inferred from the claim text.